400 related articles for article (PubMed ID: 12695913)
41. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.
Byun DS; Cho K; Ryu BK; Lee MG; Park JI; Chae KS; Kim HJ; Chi SG
Int J Cancer; 2003 Apr; 104(3):318-27. PubMed ID: 12569555
[TBL] [Abstract][Full Text] [Related]
42. p53 and PTEN/MMAC1 mutational analysis of the small-intestinal cancer.
Ito K; Kubokawa M; Harada N; Mibu R; Nawata H
Dig Liver Dis; 2003 May; 35(5):347-50. PubMed ID: 12846407
[TBL] [Abstract][Full Text] [Related]
43. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.
Konopka B; Paszko Z; Janiec-Jankowska A; Goluda M
Cancer Lett; 2002 Apr; 178(1):43-51. PubMed ID: 11849740
[TBL] [Abstract][Full Text] [Related]
44. Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers.
Kohno T; Takahashi M; Manda R; Yokota J
Genes Chromosomes Cancer; 1998 Jun; 22(2):152-6. PubMed ID: 9598803
[TBL] [Abstract][Full Text] [Related]
45. PTEN/MMAC1 in malignant melanoma and its importance for tumor progression.
Poetsch M; Dittberner T; Woenckhaus C
Cancer Genet Cytogenet; 2001 Feb; 125(1):21-6. PubMed ID: 11297763
[TBL] [Abstract][Full Text] [Related]
46. Colorectal carcinomas and PTEN/MMAC1 gene mutations.
Dicuonzo G; Angeletti S; Garcia-Foncillas J; Brugarolas A; Okrouzhnov Y; Santini D; Tonini G; Lorino G; De Cesaris M; Baldi A
Clin Cancer Res; 2001 Dec; 7(12):4049-53. PubMed ID: 11751500
[TBL] [Abstract][Full Text] [Related]
47. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
48. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
49. Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy.
Harima Y; Sawada S; Nagata K; Sougawa M; Ostapenko V; Ohnishi T
Int J Oncol; 2001 Mar; 18(3):493-7. PubMed ID: 11179477
[TBL] [Abstract][Full Text] [Related]
50. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
[TBL] [Abstract][Full Text] [Related]
51. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
Liu W; James CD; Frederick L; Alderete BE; Jenkins RB
Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744
[TBL] [Abstract][Full Text] [Related]
52. Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma.
Sükösd F; Digon B; Fischer J; Pietsch T; Kovacs G
Cancer Genet Cytogenet; 2001 Jul; 128(2):161-3. PubMed ID: 11463457
[TBL] [Abstract][Full Text] [Related]
53. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.
Dong JT; Sipe TW; Hyytinen ER; Li CL; Heise C; McClintock DE; Grant CD; Chung LW; Frierson HF
Oncogene; 1998 Oct; 17(15):1979-82. PubMed ID: 9788441
[TBL] [Abstract][Full Text] [Related]
54. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
Kurose K; Zhou XP; Araki T; Eng C
Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
[TBL] [Abstract][Full Text] [Related]
55. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.
Kim DK; Myung SJ; Yang SK; Hong SS; Kim KJ; Byeon JS; Lee GH; Kim JH; Min YI; Lee SM; Jeong JY; Song K; Jung SA
Dis Colon Rectum; 2005 Sep; 48(9):1714-22. PubMed ID: 16007494
[TBL] [Abstract][Full Text] [Related]
56. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
[TBL] [Abstract][Full Text] [Related]
57. Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders.
Aggerholm A; Grønbaek K; Guldberg P; Hokland P
Eur J Haematol; 2000 Aug; 65(2):109-13. PubMed ID: 10966170
[TBL] [Abstract][Full Text] [Related]
58. Absence of PTEN/MMAC1 gene mutations in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Tsujiuchi T; Sasaki Y; Tsutsumi M; Konishi Y
Cancer Lett; 2001 Jan; 162(2):207-11. PubMed ID: 11146227
[TBL] [Abstract][Full Text] [Related]
59. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
[TBL] [Abstract][Full Text] [Related]
60. PTEN gene alterations in lymphoid neoplasms.
Sakai A; Thieblemont C; Wellmann A; Jaffe ES; Raffeld M
Blood; 1998 Nov; 92(9):3410-5. PubMed ID: 9787181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
